ITC To Probe Drug Cos. Accused Of Using Medytox Secrets
The U.S. International Trade Commission announced Monday that it has agreed to investigate Medytox's claims that anti-wrinkle drug imports allegedly use the medical aesthetic provider's proprietary biotechnology....To view the full article, register now.
Already a subscriber? Click here to view full article